NICHD - SERVICES TO PROVIDE PATENTABILITY ADVISEMENT

尤妮斯·肯尼迪·施莱佛国家儿童健康和人类发展研究所的避孕研究分支支持研究开发能够破坏卵子发生、精子发生、正常排卵、精子成熟和/或功能的产品，从而为男性和/或女性提供安全有效的避孕药具。 拥有适当的专业知识来审查、评估和提供产品开发方面的专家咨询是成功监督的必要组成部分和关键。 为此，NICHD的CRB寻求通过建立工作人员可用的咨询资源，特别是专利性确认和意见咨询，支持赠款和合同获奖者的努力。 这些资源将为NICHD工作人员提供关于产品开发主题赠款和合同的关键投入，这些工作人员将根据需要监督网络、合作协议和/或合同。

The Contraception Research Branch (CRB) within the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) supports research to develop products that can disrupt oogenesis, spermatogenesis, normal ovulation, sperm maturation and/or function affording safe and effective contraceptives that can be implemented for men and/or women. Having the appropriate expertise available to review, evaluate, and provide expert consultation on product development is a necessary component and key for successful oversight. To this end, the NICHD’s CRB seeks to support grant and contract awardee efforts through the establishment of consulting resources available to staff, specifically, patentability advisement and opinion consulting. These resources would provide crucial input on product development themed grants and contracts for NICHD staff who oversee networks, cooperative agreements, and/or contracts, as needed.